First pre-clinical data demonstrating the potential for the Tmod™ platform in oncology published in 𝘔𝘰𝘭𝘦𝘤𝘶𝘭𝘢𝘳 𝘐𝘮𝘮𝘶𝘯𝘰𝘭𝘰𝘨𝘺